Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension

Hypertension

Volumn 57, Issue 1, 2011, Pages 79-84

  Bruno, Rosa Maria ^a   Sudano, Isabella ^b   Ghiadoni, Lorenzo ^a   Masi, Lorenzo ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

BQ123; endothelin; hypertension; microneurography; sympathetic nervous system

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; NITROPRUSSIDE SODIUM; PAPAVERINE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTRAST; ESSENTIAL HYPERTENSION; HEART BEAT; HEART RATE; HUMAN; MALE; MUSCLE CONTRACTION; MUSCLE INNERVATION; NERVE CONDUCTION; PATHOGENESIS; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ENDOTHELIN-1; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLES; NITROPRUSSIDE; PAPAVERINE; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; SYMPATHETIC NERVOUS SYSTEM;

EID: 78650802347     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.163584     Document Type: Article

References (27)

1. Esler M, Jennings G, Korner P, Blombery P, Burke F, Willett I, Leonard P. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. Clin Exp Hypertens A. 1984;6:507-521.
2. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
3. Noll G, Wenzel RR, Schneider M, Oesch V, Binggeli C, Shaw S, Weidmann P, Luscher TF. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation. 1996;93:866-869.
4. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728.
5. Dhaun N, Goddard J, Kohan DE, Pollock DM, Schiffrin EL, Webb DJ. Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension. 2008;52:452-459.
6. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon RO III, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension. 1999;33:753-758.
7. Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A. Vaso-constriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation. 1999;100: 1680-1683.
8. Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, Linseman JV, Wiens BL, Warren MS, Lindholm LH. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: A randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1423-1431.
9. Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ. Endothelin-a receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation. 2004;109:1186-1193.
10. Mosqueda-Garcia R, Inagami T, Appalsamy M, Sugiura M, Robertson RM. Endothelin as a neuropeptide: cardiovascular effects in the brainstem of normotensive rats. Circ Res. 1993;72:20-35.
11. Nakamura K, Sasaki S, Moriguchi J, Morimoto S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, Nakagawa M. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in shr-sp. J Cardiovasc Pharmacol. 1999;33:876-882.
12. Gulati A, Rebello S, Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol. 1997;273:H1177-H1186.
13. Mortensen LH. Endothelin and the central and peripheral nervous systems: a decade of endothelin research. Clin Exp Pharmacol Physiol. 1999;26:980-984.
14. Haynes WG, Hand MF, Johnstone HA, Padfield PL, Webb DJ. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. J Clin Invest. 1994;94:1359-1364.
15. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catechol-amines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979;25: 131-138.
16. Delius W, Hagbarth KE, Hongell A, Wallin BG. General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand. 1972;84:65-81.
17. Sudano I, Spieker L, Binggeli C, Ruschitzka F, Luscher TF, Noll G, Corti R. Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers. Hypertension. 2005;46:521-526.
18. Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ. Systemic eta receptor antagonism with bq-123 blocks et-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol. 2001;134:648-654.
19. Pedersen EB, Thomsen IM, Fjordside LS. Effect of bq-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study. Am J Hypertens. 2005;18:1578-1585.
20. Kumagai H, Suzuki H, Ichikawa M, Nishizawa M, Oshima N, Saruta T. Interaction between endothelin and nitric oxide in sympathetic nerve modulation in hypertensive rats. Hypertens Res. 1997;20:35-42.
21. Kitazawa T, Terasaki T, Suzuki H, Kakee A, Sugiyama Y. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides. J Pharmacol Exp Ther. 1998;286:890-895.
22. Kuwaki T, Kurihara H, Cao WH, Kurihara Y, Unekawa M, Yazaki Y, Kumada M. Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog Neurobiol. 1997;51:545-579.
23. Itoh S, van den Buuse M. Sensitization of baroreceptor reflex by central endothelin in conscious rats. Am J Physiol. 1991;260:H1106-H1112.
24. van den Buuse M, Itoh S. Central effects of endothelin on baroreflex of spontaneously hypertensive rats. J Hypertens. 1993;11:379-387.
25. Souza HC, Terzini GC, da Silva VJ, Martins-Pinge MC, Salgado HC, Salgado MC. Increased cardiac sympathetic drive and reduced vagal modulation following endothelin receptor antagonism in healthy conscious rats. Clin Exp Pharmacol Physiol. 2008;35:751-756.
26. Grassi G, Bolla G, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci (Colch). 1997;92:285-289.
27. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens. 1991;4:303-308.